Showing results (281-290 of 1,078) with videos related to
Sort By:
Pageof 108
Journal of Vascular Surgery|June 5, 2007
Objective scoring systems of medical risk: a clinical tool for selecting patients for open or endovascular abdominal aortic aneurysm repairRumi Faizer, Guy DeRose, D Kirk Lawlor, et al.Addiction (Abingdon, England)|April 8, 2015
Incarceration and injection drug use in Baltimore, MarylandBecky L Genberg, Jacquie Astemborski, David Vlahov, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|October 27, 2015
Designer exosomes as next-generation cancer immunotherapyBrandon M Bell, Isabel D Kirk, Stefanie Hiltbrunner, et al.HERD|May 23, 2020
The Correlation Between Visibility and Medical Staff Collaborative Communication in Emergency DepartmentsArsalan Gharaveis, Debajyoti Pati, D Kirk Hamilton, et al.British Journal of Urology|May 1, 1988
Ketoconazole as primary treatment of prostatic cancerL E Moffat, D Kirk, D A Tolley, et al.Journal of Neuroscience Research|August 2, 2006
Ocular phenotype in a mouse gene knockout model for infantile neuronal ceroid lipofuscinosisBo Lei, Gregory E Tullis, Mark D Kirk, et al.Cancer Cell International|January 27, 2006
Selective migration of neuralized embryonic stem cells to stem cell factor and media conditioned by glioma cell linesPeter Serfozo, Maggie S Schlarman, Chris Pierret, et al.AIDS (London, England)|June 18, 2013
Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug usersRyan P Westergaard, Timothy Hess, Jacquie Astemborski, et al.British Journal of Urology|June 1, 1994
Intravesical Evans bacille Calmette-Guérin for carcinoma in situ of the urinary bladder. Scottish Urological Oncology GroupR F Talic, T B Hargreave, M C Bishop, et al.The Journal of Urology|December 1, 1985
Growth of a malignant human urothelial cell line (J82) in a serum-free medium (HMRI-1) developed previously for normal human urotheliumM B Bishai, S Kagawa, K S Narayan, et al.Pageof 108